OABISMALL

OmniAb, Inc.

HealthcareBiotechnology
$2.52
$0.00(+0.40%)
52W$1.30
$2.79
Updated Jun 29, 02:00 AM
RSI59
RS Rating91/99
Beta1.55
Volatility63%
F-Score2/9
Mkt Cap$300M
EMERGING TREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

EMERGING TREND

OmniAb, Inc. is attempting to emerge into an uptrend but lacks full moving average alignment. Relative strength is leading (RS Rating: 91), indicating clear outperformance against the broad market. Earnings growth of 65% provides fundamental context to the price action. However, price is extended 22% above the 50-day line, increasing the risk of a mean reversion.

Relative Strength
91
out of 99
Market Leader
Trend Score
3/4
Minervini Criteria
EMERGING TREND
Risk (Beta)
1.55
vs S&P 500
HIGH BETA
52W Position
82%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

EMERGING TREND3/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$2.06
50 SMA > 100 SMA$1.88
100 SMA > 150 SMA$1.89
150 SMA > 200 SMA$1.82

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$2.38+5.66%ABOVE
50 SMA$2.06+22.32%ABOVE
100 SMA$1.88+33.94%ABOVE
150 SMA$1.89+33.21%ABOVE
200 SMA$1.82+38.63%ABOVE

Price Performance

1D+0.4%
1W+8.6%
1M-1.2%
3M+59.5%
6M+30.6%
YTD+34.0%
1Y+49.1%
3Y-18.4%
52-Week Trading Range82% from low
$2.52
52W Low$1.30
52W High$2.79

Technical Indicators

RSI (14)NEUTRAL
59.4
305070
Setup ScoreCOOL
4/10
Base depth: 57.1%

Risk Profile

Beta
1.55
52W Vol
63%
ATR
$0.20
Max DD (1Y)
-38%

Volume Analysis

Today
50D Avg
647.4K
Vol Ratio
0.00x
Liquidity
ILLIQUID

Earnings Momentum

Q2'25-15%
$-0.15
Q3'25+12%
$-0.14
Q4'25+8%
$-0.11
Q1'26+65%
$-0.06
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:-4.31%
3 Years:-31.89%
TTM:+8.11%

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:+20.69%

Stock Price CAGR

10 Years:-12.66%
5 Years:-23.72%
3 Years:-18.41%
1 Year:+49.11%

Return on Equity

10Y Avg:-13.2%
5Y Avg:-15.7%
3Y Avg:-19.8%
Last Year:-20.3%

Key Metrics

Market Cap$300M
Gross Margin-18.2%
Net Margin-3.5%
Piotroski F-Score2/9

Frequently Asked Questions

Is OABI in an uptrend right now?

OABI has a trend score of 3/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 3 of 4 trend criteria are met.

Is OABI overbought or oversold?

OABI's RSI (14) is 59. The stock is in neutral territory, neither overbought nor oversold.

Is OABI outperforming the market?

OABI has a Relative Strength (RS) Rating of 91 out of 99. Yes, OABI is a market leader, outperforming 91% of all stocks over the past 12 months.

Where is OABI in its 52-week range?

OABI is trading at $2.52, which is 90% of its 52-week high ($2.79) and 82% above its 52-week low ($1.30).

How volatile is OABI?

OABI has a Beta of 1.55 and 52-week volatility of 63%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.